Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Hyperparathyroidism Drug Etelcalcetide Meets Primary Endpoint in Japan PIII: Ono
May 25, 2016
- Toyama Chemical Files Ozex for Mycoplasma Pneumoniae at Request of Academic Societies
May 25, 2016
- Bardoxolone Methyl Improves Renal Function in Japan PII: Kyowa Kirin
May 24, 2016
- PCSK9 Inhibitor Alirocumab Lowers LDL-C in Japanese Diabetes Patients: PIII Sub-Analysis
May 24, 2016
- Japan’s Top 3 Drug Makers Join Forces on Biomarker Research
May 24, 2016
- Repatha Shows Safety, Efficacy in Japanese Patients Regardless of Glycemic Status: Subanalysis Data
May 24, 2016
- Ozawa to Step Down as J-TEC CEO, Fujifilm’s Hiruma to Take Over
May 23, 2016
- Jiangsu Hengrui Medicine Eyes Launch of 2-3 Generics in Japan Every Year: CEO
May 23, 2016
- Generic Makers Enjoy Revenue Rises as Govt Tailwinds Continue: Jiho Tally
May 23, 2016
- Chugai, Osaka Univ. Clinch 10 Billion Yen Immunology Pact
May 20, 2016
- Ono Ties Up with Univ. of Tokyo Venture for Antibody Drug
May 19, 2016
- Suzuken Outstrips Medipal in Drug Wholesaling Biz on Hep C Boom: Jiho Tally
May 19, 2016
- Takecab Most Heavily Pitched Drug for 3 Consecutive Months: Anterio
May 18, 2016
- Harvoni Tops Japan Yearly Sales Ranking Only 7 Months after Launch: IMS
May 18, 2016
- ASKA Dissolves Generic JV with Actavis
May 17, 2016
- Medipal to Set Up Subsidiary for Specialty Drugs
May 17, 2016
- Lilly, Kanazawa Medical Univ. Ink Research Deal on Diffuse-Type Gastric Cancer
May 17, 2016
- Top 8 Japan Drug Makers Relish 2.6-Fold Operating Profit Jump on Global Brands
May 17, 2016
- Chugai’s CellCept, Generic Versions Approved for Lupus Nephritis
May 17, 2016
- Nippon Kayaku Faces Damage Suit over Elplat Patent
May 17, 2016
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…